# Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease

> **NCT05948761** · PHASE1,PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **OTHER:** Hypoxia through modified hypoxic generator
- **OTHER:** Normoxia through hypoxic generator without active elements

## Key facts

- **NCT ID:** NCT05948761
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-04
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05948761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05948761, "Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05948761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*